Analysis of the drug assortment for treating nicotine dependence presented at the pharmaceutical market of Ukraine
DOI:
https://doi.org/10.24959/nphj.14.1949Keywords:
marketing research, aassortment, medicines for treating nicotine dependence, nicotine addictionAbstract
The analysis of the drug assortment for treating nicotine dependence presented at the Ukrainian pharmaceutical market has been carried out according to the ATC-classification and countriesproducers with the purpose of providing the population with effective, qualitative and safe medicines. Two types of therapy are used for nicotine addiction: nicotine replacement therapy and therapy with the use of medicines, which do not contain nicotine. In the process of our investigations it has been found that 11 trade names (TD) of medicines for treating nicotine dependence (MTND) have been registered in Ukraine. Among them there are 8 nicotine-containing drugs, 1 medicine contains cytisine, 1 includes varenicline and 1 is a homeopathic medicine produced by 5 countries. It has been determined that the majority of medicines for treating nicotine dependence are presented by foreign producers at the Ukrainian market. The majority of the drug assortment for treating nicotine dependence is imported drugs of such pharmaceutical companies as McNeil, AB (Sweden); Novartis Consumer Health, S.A. (Switzerland); Sopharma (Bulgaria), Pfizer (the USA). The analysis of medicines for treating nicotine dependence has been carried out by medicinal forms. Medicines for treating nicotine dependence are presented at the market of Ukraine in such forms as chewing gums, tablets, transdermal plasters, granules. According to the maximum indexes received the assortment contour of the target segment of the Ukrainian pharmaceutical market of MTND (macrocontour) has been developed. The macrocontour of the target market segment can be used for studying the assortment of a particular chemist’s shop with the purpose of possibility of the assortment extension.
References
Dremova N.B., Ovod A.I. // Kursk scientific and practical reporter “Man and its health”. – 2006. – №3. – P. 41-54.
Golichenko M. Canadian HIV/AIDS Legal Network. – 2011. – P. 8-13.
Holtfreter B. // J. of Clin. Periodontol. – 2010. – Vol. 37. – Р. 211-219.
Kolassa E. // J. of Pharmac. Markеting and Management. – 2002. – Vol. 14, №3-4. – P. 101-108.
Malhotra S. // J. of Pharmac. Marketing and Management. – 2004. – Vol. 16, №4. – P. 97-106.
Martsevich S.U., Lukina U.V. // [Electronic resource]: – Режим доступа: http://elibrary.ru/item.asp?id=18747155
Mnushko Z.N., Pestun I.V. Theory and practice of marketing investigations in pharmacy. – Kharkov: publ. NPhaU, 2008. – P. 15-22.
Niklaus P. Lang // J. of Clin. Periodontol. – 2009. – Vol. 36. – Р. 3-8.
Philip M. Preshaw // J. of Clin. Periodontol. – 2009. – Vol. 36. – Р. 1-2.
Rx-index. Classifier of medical preparations.[Electronic resource]: – Regime of access :http://www.rxindex. com.ua/atc#N07BA
Smirnov V.K., Ermolova O.I., Speranskaya O.I. // Narcol. – 2010. – №6. – P. 36-39.
State register of medicines [Electronic resource]: – Regime of access: http://www.drlz.Kiev.ua/
Tonnesen P. // JAMA. – 2003. – Vol. 269. – P. 1268-1271.
Velitchka D., Weitz B. // J. of Marketing. – 2006. – Vol. 70, №1. – P. 48-56.
Ziryanov S.K., Belousov U.B. // Preventive Medicine. – 2010. – Vol. 13, №6. – P. 21-23.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
